{"meta":{"query_hash":"b648535b812a","filters":{"venue":"Journal of Generic Medicines The Business Journal for the Generic Medicines Sector"},"cohort_total":19,"direct_labels_cover":0,"predictions_cover":19,"exported":19,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/b648535b812a","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Generic+Medicines+The+Business+Journal+for+the+Generic+Medicines+Sector"},"results":[{"id":"W1978784436","doi":"10.1057/palgrave.jgm.4940034","title":"Editorial: Canada First to Pass Legislation on Delivering Generic Medicines to Developing Countries","year":2004,"lang":"en","type":"editorial","venue":"Journal of Generic Medicines The Business Journal for the Generic Medicines Sector","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Innovative Medicines Canada","funders":"","keywords":"Legislation; Business; Developing country; Medicine; International trade; Political science; Law; Economic growth; Economics","score_opus":0.052324298369772655,"score_gpt":0.2877537100870722,"score_spread":0.23542941171729953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978784436","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000045733348,0.003249288,0.00006521267,0.07524093,0.91913855,0.00004086598,0.00011613967,0.00004402972,0.0020592534],"genre_scores_gemma":[0.001068949,0.004583724,0.00019614678,0.076862395,0.8913583,0.000057645102,0.00009427349,0.00007782954,0.025700644],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99100024,0.0008848622,0.00087109883,0.0008229402,0.0054212185,0.0009996031],"domain_scores_gemma":[0.9565405,0.011506926,0.0021208634,0.0009799841,0.023592763,0.005259008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009905716,0.0051435116,0.006460817,0.0071483403,0.008347272,0.011117452,0.0061816717,0.035559736,0.012556438],"category_scores_gemma":[0.04340519,0.0017528889,0.004221659,0.0042112023,0.0046923463,0.003732229,0.0014494212,0.035765704,0.007345322],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017962577,0.000007911124,0.000014608654,0.000058023186,0.000012312365,0.000058643633,0.0000067020824,0.000015056249,0.000015246895,0.00008393482,0.9988367,0.0008729726],"study_design_scores_gemma":[0.00010519274,0.000029277511,0.00062802585,0.00051004096,0.00015464661,0.00014820836,0.000088522895,0.00020534176,0.00014228193,0.00061699946,0.9973346,0.000036937006],"about_ca_topic_score_codex":0.07592956,"about_ca_topic_score_gemma":0.19511457,"teacher_disagreement_score":0.9240704,"about_ca_system_score_codex":0.017561525,"about_ca_system_score_gemma":0.021313217,"threshold_uncertainty_score":0.15097517},"labels":[],"label_agreement":null},{"id":"W1990933841","doi":"10.1057/jgm.2008.1","title":"Climate of Change Continues in Canada","year":2008,"lang":"en","type":"article","venue":"Journal of Generic Medicines The Business Journal for the Generic Medicines Sector","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Liberian dollar; Market share; Business; Brand names; Generic drug; Reimbursement; Value (mathematics); Marketing; Industrial organization; Economics; Finance; Health care; Economic growth; Drug","score_opus":0.19256701491646183,"score_gpt":0.2973795869913426,"score_spread":0.10481257207488076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990933841","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12884632,0.019642584,0.001308788,0.44190627,0.0051256153,0.00011475889,0.007349986,0.00041232572,0.3952933],"genre_scores_gemma":[0.88232934,0.01732635,0.0010813194,0.04693059,0.0010757329,0.00005829226,0.0019007778,0.00018998607,0.04910766],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99618405,0.00017577293,0.00007142105,0.00024063009,0.0015766699,0.0017514954],"domain_scores_gemma":[0.9964101,0.00017383945,0.00030645312,0.00008219806,0.0017352467,0.0012921307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013513685,0.0003224577,0.00056992634,0.001632918,0.013353164,0.009813722,0.0012753225,0.0025389497,0.01513151],"category_scores_gemma":[0.0038965289,0.00021631728,0.0006574393,0.005056116,0.0056825783,0.0025295888,0.003460068,0.0032438969,0.0007411329],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020535664,0.000101281505,0.06433814,0.00089183386,0.00013522586,0.0025798955,0.020618832,0.0037518737,0.001425069,0.26072735,0.5504513,0.09477388],"study_design_scores_gemma":[0.000012114286,0.000015796617,0.066741996,0.00019459389,0.000017574837,0.00014240228,0.014886512,0.000516855,0.00013146391,0.008766937,0.90849286,0.000080883816],"about_ca_topic_score_codex":0.9830702,"about_ca_topic_score_gemma":0.9885167,"teacher_disagreement_score":0.10890534,"about_ca_system_score_codex":0.10890534,"about_ca_system_score_gemma":0.17640282,"threshold_uncertainty_score":0.7901672},"labels":[],"label_agreement":null},{"id":"W1993877811","doi":"10.1177/1741134312445867","title":"<i>Sanofi-Aventis et al. v. Apotex Inc. et al.</i> : The one hundred eight million dollar question","year":2012,"lang":"en","type":"article","venue":"Journal of Generic Medicines The Business Journal for the Generic Medicines Sector","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Damages; Settlement (finance); Liberian dollar; Denial; Law; Business; Political science; Finance; Psychology","score_opus":0.12291800667644992,"score_gpt":0.28031494319359923,"score_spread":0.1573969365171493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993877811","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014824038,0.008027591,0.0016475065,0.44595975,0.004437952,0.00018744441,0.002535945,0.00032767138,0.5220521],"genre_scores_gemma":[0.12748829,0.0033187754,0.0013505543,0.7548515,0.0027700055,0.0003923553,0.00068277976,0.00007695963,0.10906883],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9931426,0.00089701806,0.0004055788,0.0008187505,0.002681202,0.0020548238],"domain_scores_gemma":[0.99458355,0.0033819557,0.00051961624,0.00022360888,0.0009769833,0.00031427538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054707117,0.0008504482,0.00067346805,0.00123801,0.008381238,0.010668006,0.0029926396,0.033946108,0.01030119],"category_scores_gemma":[0.013218741,0.00098623,0.0013542288,0.0016539539,0.004308966,0.0043342854,0.002090775,0.014071835,0.004590622],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006500039,0.00004436456,0.0011827955,0.000087063454,0.00002050218,0.00041708915,0.0008496804,0.00013122779,0.00049627066,0.2680433,0.72391856,0.0047442233],"study_design_scores_gemma":[0.00016112831,0.000119049124,0.01028706,0.00065651466,0.00009349121,0.0004779447,0.0015978873,0.0006981195,0.0013942058,0.051966224,0.9323534,0.00019495335],"about_ca_topic_score_codex":0.09074227,"about_ca_topic_score_gemma":0.17087336,"teacher_disagreement_score":0.09074227,"about_ca_system_score_codex":0.0083865505,"about_ca_system_score_gemma":0.011511714,"threshold_uncertainty_score":0.18042815},"labels":[],"label_agreement":null},{"id":"W2051735118","doi":"10.1177/1741134311408275","title":"The 2011 Canada-European Union Comprehensive Economic and Trade Agreement: an economic impact assessment of the EU’s proposed pharmaceutical intellectual property provisions","year":2011,"lang":"en","type":"article","venue":"Journal of Generic Medicines The Business Journal for the Generic Medicines Sector","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University of Calgary","funders":"","keywords":"European union; Intellectual property; Economic impact analysis; International trade; International economics; Business; Trade agreement; Economics; Political science; Free trade; Law","score_opus":0.17233999614838943,"score_gpt":0.2933692034571246,"score_spread":0.12102920730873515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051735118","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26457027,0.005287239,0.005181746,0.029877374,0.000615161,0.0018601639,0.008562174,0.00023759276,0.6838083],"genre_scores_gemma":[0.8958971,0.003013733,0.01093833,0.01632292,0.00016052586,0.00092325173,0.004708783,0.00009706671,0.06793819],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.93904245,0.005029213,0.0012356975,0.0014850482,0.042789433,0.010418159],"domain_scores_gemma":[0.9691394,0.009198555,0.0019494924,0.0013167346,0.016212964,0.0021828592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023522997,0.0013346195,0.0011206095,0.006944272,0.009925602,0.017716903,0.0046959245,0.009250577,0.0042131627],"category_scores_gemma":[0.051434956,0.0011963443,0.0027199802,0.007034364,0.005004542,0.0028932295,0.004573389,0.00611505,0.00048902293],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001015362,0.0005515168,0.021820605,0.00046171964,0.00034171785,0.0011910428,0.0015068358,0.036004025,0.0015238906,0.8148058,0.08667379,0.034103688],"study_design_scores_gemma":[0.0015255117,0.0012519374,0.25835717,0.0015500936,0.0014998261,0.00045008198,0.0077449824,0.041370183,0.009993841,0.05590194,0.61915004,0.0012043451],"about_ca_topic_score_codex":0.9298305,"about_ca_topic_score_gemma":0.9293284,"teacher_disagreement_score":0.13461576,"about_ca_system_score_codex":0.13461576,"about_ca_system_score_gemma":0.2448309,"threshold_uncertainty_score":0.9767103},"labels":[],"label_agreement":null},{"id":"W2139728736","doi":"10.1177/1741134312448062","title":"Deficiencies in generic product dossiers as submitted to the WHO Prequalification of Medicines Programme","year":2012,"lang":"en","type":"article","venue":"Journal of Generic Medicines The Business Journal for the Generic Medicines Sector","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Medicine; Product (mathematics); Malaria; Tuberculosis; Quality (philosophy); Pharmacy; Traditional medicine; Family medicine","score_opus":0.15857684763618016,"score_gpt":0.38484092979332174,"score_spread":0.22626408215714158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139728736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9736984,0.003494136,0.0044558626,0.0012414374,0.00008655602,0.0007782657,0.0034243122,0.00017973692,0.012641328],"genre_scores_gemma":[0.98824906,0.0007977278,0.0062763747,0.00067020813,0.000049753726,0.00014378414,0.002308314,0.000038068716,0.0014667019],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.94165707,0.018582607,0.014102928,0.0029365271,0.021432675,0.0012881084],"domain_scores_gemma":[0.7945216,0.05926665,0.10015693,0.016028086,0.02846181,0.0015649294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.043738008,0.00029173057,0.00056388223,0.005602458,0.0006084852,0.0016870525,0.0012430104,0.00083638873,0.0024894397],"category_scores_gemma":[0.11314107,0.0003662223,0.0007023103,0.0036875848,0.0011454653,0.0012545312,0.0014963242,0.00060030003,0.0006352633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015618469,0.00031707555,0.76278996,0.0014639726,0.00018713347,0.00068907486,0.0040972508,0.0015512839,0.008889442,0.0016520448,0.0027043016,0.21409655],"study_design_scores_gemma":[0.00009102438,0.0023354,0.9375222,0.00073320896,0.00017946163,0.0031094407,0.0023506235,0.0020604457,0.015482346,0.0008584929,0.03515503,0.00012233669],"about_ca_topic_score_codex":0.0027166773,"about_ca_topic_score_gemma":0.0021654118,"teacher_disagreement_score":0.043738008,"about_ca_system_score_codex":0.0027031563,"about_ca_system_score_gemma":0.002541197,"threshold_uncertainty_score":0.23131144},"labels":[],"label_agreement":null},{"id":"W2322087671","doi":"10.1177/1741134314545250","title":"Selection of the comparator product in the World Health Organisation Prequalification of Medicines Programme","year":2013,"lang":"en","type":"article","venue":"Journal of Generic Medicines The Business Journal for the Generic Medicines Sector","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Bioequivalence; Medicine; Product (mathematics); Innovator; Quality (philosophy); Pharmacology; Business","score_opus":0.14693579883615218,"score_gpt":0.33541004693518345,"score_spread":0.18847424809903127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322087671","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16708659,0.05274569,0.11407721,0.019041335,0.017324192,0.16969855,0.024157995,0.0022901783,0.43357828],"genre_scores_gemma":[0.44969448,0.020148009,0.30163562,0.025119955,0.0023193904,0.08006495,0.022874039,0.0011489604,0.09699468],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.987817,0.004870384,0.002016018,0.0009902504,0.0038503448,0.00045610176],"domain_scores_gemma":[0.9947648,0.0013109942,0.0009421562,0.00061853614,0.0019285,0.0004349601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014530962,0.0006606879,0.0012717091,0.0014911509,0.0007711352,0.0020874368,0.0013409569,0.0031568978,0.02854115],"category_scores_gemma":[0.024487894,0.00038185445,0.0013729543,0.0009096152,0.0009656064,0.0011859224,0.0010742996,0.0016565275,0.011535677],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023664856,0.0035010073,0.006390546,0.01054147,0.00022725058,0.0010853477,0.0008761775,0.00049237796,0.06907533,0.012982693,0.0812214,0.7899415],"study_design_scores_gemma":[0.0040437095,0.01628359,0.014439691,0.005071798,0.00055651536,0.0016365822,0.000382982,0.0008680821,0.05895494,0.0032194161,0.8943242,0.00021842332],"about_ca_topic_score_codex":0.0005324366,"about_ca_topic_score_gemma":0.00065892754,"teacher_disagreement_score":0.02854115,"about_ca_system_score_codex":0.0009212128,"about_ca_system_score_gemma":0.0024225796,"threshold_uncertainty_score":0.09547967},"labels":[],"label_agreement":null},{"id":"W2525448133","doi":"10.1177/1741134316669967","title":"A comparison of mechanisms for setting generic drug prices in Canada","year":2016,"lang":"en","type":"article","venue":"Journal of Generic Medicines The Business Journal for the Generic Medicines Sector","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University of Calgary","funders":"","keywords":"Reimbursement; Procurement; Benchmarking; Competition (biology); Business; Incentive; Discretion; Generic drug; Pharmacy; Public economics; Actuarial science; Drug; Industrial organization; Economics; Marketing; Microeconomics; Pharmacology; Medicine; Health care","score_opus":0.09433249734598782,"score_gpt":0.31471393864421765,"score_spread":0.22038144129822984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525448133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7022483,0.017749427,0.008212854,0.016352113,0.00025049664,0.001214909,0.008117628,0.0004452405,0.24540912],"genre_scores_gemma":[0.98394245,0.0037537557,0.0037108546,0.0007273199,0.000026058799,0.00008061703,0.0010847705,0.000033446948,0.006640822],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9912854,0.0010260908,0.00038682844,0.0004166191,0.0044231266,0.002461951],"domain_scores_gemma":[0.98898005,0.0028398728,0.0009695415,0.0003708961,0.0055725854,0.0012669951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004443487,0.00046877653,0.0006799741,0.0037552677,0.0039835996,0.005381864,0.0024508168,0.0011617551,0.004944932],"category_scores_gemma":[0.019774033,0.00047178715,0.0010401222,0.005991971,0.0015836615,0.0012774421,0.0015817101,0.0011722572,0.00024263965],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026750218,0.0006044111,0.17302352,0.0026158714,0.00091032044,0.0011706959,0.0047417004,0.06047511,0.0038039712,0.4306134,0.06545798,0.25390807],"study_design_scores_gemma":[0.0011704717,0.0006930431,0.735766,0.0010016134,0.0013110472,0.00056690583,0.009684451,0.063518524,0.0050917547,0.015997909,0.16455646,0.0006417803],"about_ca_topic_score_codex":0.99286544,"about_ca_topic_score_gemma":0.99417454,"teacher_disagreement_score":0.16450296,"about_ca_system_score_codex":0.16450296,"about_ca_system_score_gemma":0.12783115,"threshold_uncertainty_score":0.96905816},"labels":[],"label_agreement":null},{"id":"W2530530268","doi":"10.1177/1741134316673227","title":"Physicians’ loyalty to branded medicines in low-middle-income countries: A structural equation modeling","year":2016,"lang":"en","type":"article","venue":"Journal of Generic Medicines The Business Journal for the Generic Medicines Sector","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Loyalty; Structural equation modeling; Medical prescription; Marketing; Brand loyalty; Psychology; Health care; Affect (linguistics); Business; Medicine; Family medicine; Nursing; Political science","score_opus":0.3567624069152197,"score_gpt":0.4815236557034066,"score_spread":0.1247612487881869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530530268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99535143,0.00024688308,0.0022880333,0.00071654696,0.000024892373,0.00005230776,0.00039077873,0.000020560106,0.0009085314],"genre_scores_gemma":[0.997686,0.00016851956,0.0011859179,0.00008025496,0.000013505055,0.00005404655,0.00041747317,0.0000036153415,0.00039059971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99736905,0.0016183499,0.00013829701,0.00029347697,0.00016497144,0.00041580584],"domain_scores_gemma":[0.991222,0.0066878963,0.0010066753,0.00025202308,0.0004573011,0.00037415492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054002753,0.00065231585,0.0009607706,0.001768409,0.0012009494,0.0019996576,0.001269495,0.0015946174,0.0047357623],"category_scores_gemma":[0.008410536,0.00076738995,0.002478104,0.0017746725,0.0006814058,0.0009852387,0.0016027967,0.0018970707,0.00044090353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023817002,0.0011607939,0.9560419,0.000097004384,0.00071424193,0.0004735077,0.0019460729,0.02649077,0.00014017927,0.002401527,0.0016970714,0.008598703],"study_design_scores_gemma":[0.00021376941,0.0012469309,0.39322597,0.00038084574,0.00083661394,0.0002970148,0.0062538893,0.5917742,0.00021385546,0.0034409305,0.0020303824,0.00008557788],"about_ca_topic_score_codex":0.049242612,"about_ca_topic_score_gemma":0.029052392,"teacher_disagreement_score":0.049242612,"about_ca_system_score_codex":0.0016254955,"about_ca_system_score_gemma":0.0022537368,"threshold_uncertainty_score":0.097911954},"labels":[],"label_agreement":null},{"id":"W2889860594","doi":"10.1177/1741134318799385","title":"Establishing healthy pharmaceutical regulations on statutory exclusivity: Lessons from the experience in the European Union, Canada, South Korea, Australia, and the United States","year":2018,"lang":"en","type":"article","venue":"Journal of Generic Medicines The Business Journal for the Generic Medicines Sector","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Statutory law; Legislation; European union; Business; International trade; Constructive; Law; Political science; Process (computing)","score_opus":0.1891385280060947,"score_gpt":0.35939947576919407,"score_spread":0.17026094776309936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889860594","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21468237,0.12472892,0.016377583,0.2976601,0.0018812501,0.0006756363,0.00030968597,0.0001499121,0.34353456],"genre_scores_gemma":[0.86509067,0.051502008,0.016166667,0.0504144,0.0003170683,0.00014445047,0.00021145004,0.000117480195,0.016035717],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9576298,0.016735548,0.0034470705,0.0028963105,0.013802556,0.005488728],"domain_scores_gemma":[0.81583005,0.105171904,0.007273004,0.0056845467,0.058972795,0.0070676515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.09046639,0.00048729917,0.00065709517,0.0037972522,0.012719834,0.016241727,0.0029223645,0.005387324,0.0022104902],"category_scores_gemma":[0.081582725,0.00061671465,0.00075997,0.0067299884,0.025661286,0.0102600325,0.0054269074,0.008460934,0.00019120383],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008032133,0.00019324894,0.014531406,0.0014833072,0.000052928048,0.0024277798,0.16744924,0.0016110556,0.001202675,0.54903895,0.034576442,0.22735272],"study_design_scores_gemma":[0.000038627833,0.00019122649,0.03125635,0.008863275,0.000081440776,0.00075416616,0.16006133,0.0008280004,0.0023311956,0.039412435,0.75590056,0.00028141626],"about_ca_topic_score_codex":0.80171233,"about_ca_topic_score_gemma":0.8375875,"teacher_disagreement_score":0.19828767,"about_ca_system_score_codex":0.084970236,"about_ca_system_score_gemma":0.266249,"threshold_uncertainty_score":0.6165051},"labels":[],"label_agreement":null},{"id":"W2905138060","doi":"10.1177/1741134318810061","title":"Tough medicine: Ensuring access to affordable drugs requires fixing trade agreements starting with NAFTA","year":2018,"lang":"en","type":"article","venue":"Journal of Generic Medicines The Business Journal for the Generic Medicines Sector","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Intellectual property; International trade; General partnership; Negotiation; Market access; Business; Biosimilar; International trade law; Modernization theory; Subsidy; Balance (ability); International economics; Economics; Law; Economic growth; Political science; Finance; Medicine; Market economy","score_opus":0.14072967902078418,"score_gpt":0.3383205404430396,"score_spread":0.19759086142225543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905138060","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034009743,0.01399695,0.02934477,0.56958854,0.009832356,0.00026968223,0.00036758542,0.00043336485,0.342157],"genre_scores_gemma":[0.6081378,0.008631155,0.05626176,0.24212,0.003680923,0.0005972048,0.00042863446,0.00025435092,0.07988822],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.98378307,0.004942527,0.00094106,0.0022541564,0.0056963707,0.0023829285],"domain_scores_gemma":[0.9834246,0.0071464297,0.0020301817,0.0018887746,0.0040307348,0.0014793935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023063859,0.00079249643,0.0008303635,0.0017671216,0.006717279,0.013050569,0.0018331062,0.01573881,0.015730752],"category_scores_gemma":[0.050020054,0.00048526333,0.0014062016,0.0011428179,0.0104145,0.017254466,0.0054773907,0.012798156,0.0027278662],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087996494,0.00005213719,0.00097288314,0.000171462,0.000033627617,0.0002684905,0.001494421,0.0003132925,0.0009474198,0.9226961,0.041311,0.031651124],"study_design_scores_gemma":[0.00005363518,0.0001364133,0.0020867037,0.0009502653,0.000041494066,0.00025571813,0.0013771752,0.00060480786,0.00097427686,0.3517604,0.6416611,0.00009806627],"about_ca_topic_score_codex":0.019471772,"about_ca_topic_score_gemma":0.01291046,"teacher_disagreement_score":0.023063859,"about_ca_system_score_codex":0.007889775,"about_ca_system_score_gemma":0.016572734,"threshold_uncertainty_score":0.121974766},"labels":[],"label_agreement":null},{"id":"W2989800361","doi":"10.1177/1741134319886627","title":"The test data provision of USMCA: A potential to promote or negate the timely access to genetically engineered biologics?","year":2019,"lang":"en","type":"article","venue":"Journal of Generic Medicines The Business Journal for the Generic Medicines Sector","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Intellectual property; TRIPS architecture; TRIPS Agreement; International trade; Test (biology); Trade agreement; Treaty; Business; Human rights; Law; Law and economics; Political science; Economics; Free trade; Engineering","score_opus":0.16597550857809093,"score_gpt":0.2935024081615318,"score_spread":0.12752689958344085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989800361","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027539205,0.015281541,0.029851528,0.61967915,0.00475864,0.0002381163,0.0015359636,0.0006780182,0.30043787],"genre_scores_gemma":[0.4341333,0.016935432,0.03921637,0.42762855,0.004218278,0.00058460276,0.0017841787,0.00060982315,0.07488959],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.95479333,0.010861383,0.0017805821,0.0053355885,0.023283733,0.003945311],"domain_scores_gemma":[0.89206773,0.055518884,0.010002352,0.013452027,0.02464159,0.0043173623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04300812,0.00057446276,0.0009979935,0.0021038575,0.004681629,0.017378889,0.0063050245,0.017120138,0.011031322],"category_scores_gemma":[0.085380696,0.00081944553,0.0015046112,0.0027976488,0.01605947,0.015408355,0.0076801972,0.01766936,0.0029720906],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057351514,0.000049860177,0.0029712003,0.00022541628,0.000031058666,0.0006536086,0.0012815684,0.00036569242,0.0011307208,0.882127,0.07061677,0.040489726],"study_design_scores_gemma":[0.00003209743,0.00009457065,0.0019845897,0.0011883272,0.00005490204,0.001318182,0.0012918689,0.0008664377,0.0033340368,0.10222018,0.8875132,0.00010151059],"about_ca_topic_score_codex":0.062990606,"about_ca_topic_score_gemma":0.05980809,"teacher_disagreement_score":0.062990606,"about_ca_system_score_codex":0.012246166,"about_ca_system_score_gemma":0.042961393,"threshold_uncertainty_score":0.22745138},"labels":[],"label_agreement":null},{"id":"W3016416029","doi":"10.1177/1741134320918339","title":"A Novel Development and Portfolio Management Strategy for Generic Small Molecule Drug Products: Watergile ANDA","year":2020,"lang":"en","type":"article","venue":"Journal of Generic Medicines The Business Journal for the Generic Medicines Sector","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Apotex (Canada)","funders":"","keywords":"Portfolio; Business; New product development; Commercialization; Project portfolio management; Drug development; Product (mathematics); Process (computing); Risk analysis (engineering); Process management; Marketing; Industrial organization; Drug; Economics; Computer science; Finance; Project management; Pharmacology; Medicine; Management","score_opus":0.13791547266274154,"score_gpt":0.2835873039882082,"score_spread":0.14567183132546666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016416029","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030657854,0.0020789083,0.8241394,0.03725732,0.00037514715,0.0013366995,0.0003323873,0.0015956052,0.1022266],"genre_scores_gemma":[0.42613244,0.0015350566,0.53181475,0.004807836,0.00046243565,0.0008158793,0.0004603789,0.00018197803,0.033789195],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99102306,0.00400846,0.0004262871,0.0011827748,0.0028065701,0.00055290974],"domain_scores_gemma":[0.9933915,0.001953856,0.000916285,0.00092936045,0.0019528193,0.00085624575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014684566,0.0009309727,0.00094498094,0.004228824,0.0015746691,0.00948187,0.0021904567,0.0028938309,0.008659621],"category_scores_gemma":[0.021755215,0.000596594,0.0010292826,0.0022086443,0.0017160525,0.0104564475,0.007282763,0.0020445008,0.0017327443],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001783409,0.00044465586,0.004887461,0.0001946463,0.00013233998,0.0005648199,0.0006114263,0.020667752,0.0021379744,0.41841468,0.03091267,0.52085316],"study_design_scores_gemma":[0.00021539311,0.0006287453,0.003605292,0.00039306024,0.00011507698,0.0007027206,0.00093186804,0.266308,0.004237479,0.50725204,0.21542871,0.00018158808],"about_ca_topic_score_codex":0.0030266636,"about_ca_topic_score_gemma":0.003145399,"teacher_disagreement_score":0.014684566,"about_ca_system_score_codex":0.004035988,"about_ca_system_score_gemma":0.009103154,"threshold_uncertainty_score":0.07766038},"labels":[],"label_agreement":null},{"id":"W3121226665","doi":"10.1057/jgm.2010.14","title":"Ever-Greening: A Status Check in Selected Countries","year":2010,"lang":"en","type":"article","venue":"Journal of Generic Medicines The Business Journal for the Generic Medicines Sector","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Mylan","keywords":"Business; Greening; Product (mathematics); Index (typography); Developing country; Duration (music); Generic drug; International trade; Development economics; International economics; Economics; Economic growth; Medicine; Political science","score_opus":0.06957175371250879,"score_gpt":0.29925292180352275,"score_spread":0.22968116809101397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121226665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9053883,0.024630627,0.00047435303,0.013132904,0.00047811697,0.00012046718,0.007346468,0.00015729484,0.048271485],"genre_scores_gemma":[0.9849029,0.0077904724,0.00041303644,0.0014800383,0.00014513572,0.000031329277,0.0021141828,0.000031258125,0.0030915947],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895144,0.0001860172,0.0001890686,0.0001141785,0.0002824657,0.00027682277],"domain_scores_gemma":[0.9873704,0.001771627,0.0053177862,0.000596523,0.0037227778,0.0012209866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003120998,0.00019585817,0.00038257337,0.0043776287,0.0008325033,0.0025888719,0.00044335154,0.0007220773,0.00350136],"category_scores_gemma":[0.006306943,0.00020204755,0.00043032423,0.007928319,0.0008029894,0.002137243,0.0013299077,0.00066972885,0.00048359914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010129575,0.00015150932,0.82402176,0.0012536983,0.00016428561,0.0016567877,0.0036666638,0.0005229881,0.0014800307,0.00433056,0.025658347,0.13608049],"study_design_scores_gemma":[0.00003299221,0.00028489318,0.93847084,0.00042000113,0.00008726943,0.00079763576,0.0060824994,0.00018775564,0.0008074649,0.00035739833,0.052440964,0.000030311845],"about_ca_topic_score_codex":0.013268536,"about_ca_topic_score_gemma":0.016383987,"teacher_disagreement_score":0.013268536,"about_ca_system_score_codex":0.0010673786,"about_ca_system_score_gemma":0.0014864949,"threshold_uncertainty_score":0.026382625},"labels":[],"label_agreement":null},{"id":"W3163186261","doi":"10.1177/17411343211001424","title":"Does regulatory chill still concern states?","year":2021,"lang":"en","type":"article","venue":"Journal of Generic Medicines The Business Journal for the Generic Medicines Sector","topic":"International Arbitration and Investment Law","field":"Business, Management and Accounting","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Legislature; Government (linguistics); Arbitration; Law and economics; State (computer science); Investment (military); Argument (complex analysis); Treaty; Law; Business; Political science; Economics; Politics; Medicine","score_opus":0.036827512124114045,"score_gpt":0.2616703558542059,"score_spread":0.22484284373009183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163186261","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012572824,0.0084644845,0.005092834,0.7270801,0.0027872077,0.00003270771,0.00006788502,0.000068867696,0.24383314],"genre_scores_gemma":[0.47212535,0.008257176,0.0014716216,0.47308144,0.0037163899,0.00011628054,0.00006928228,0.00009357029,0.041068856],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.985664,0.0051603736,0.00049193786,0.0025082466,0.0029199899,0.0032553487],"domain_scores_gemma":[0.97936237,0.014350588,0.0016391652,0.0012362194,0.002302599,0.0011089983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014191193,0.0003985429,0.0007757361,0.0009103457,0.007382677,0.020406185,0.0020095436,0.025004657,0.013379223],"category_scores_gemma":[0.031100633,0.00042840626,0.0011409384,0.0016177994,0.019105315,0.020990232,0.004701696,0.024431735,0.0020344076],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000787774,0.000012872212,0.0005962615,0.00004772601,0.000007079578,0.00018812456,0.002334044,0.00011470044,0.00007329648,0.968983,0.020559216,0.007075789],"study_design_scores_gemma":[0.00001792008,0.00005418579,0.0013219268,0.0007451474,0.00003201239,0.00044212778,0.0068243397,0.000486599,0.0005152293,0.48711628,0.5023737,0.00007054574],"about_ca_topic_score_codex":0.017506909,"about_ca_topic_score_gemma":0.013168052,"teacher_disagreement_score":0.025004657,"about_ca_system_score_codex":0.0072299223,"about_ca_system_score_gemma":0.010680976,"threshold_uncertainty_score":0.07505113},"labels":[],"label_agreement":null},{"id":"W3173567414","doi":"10.1177/17411343211008589","title":"The anatomy of CUSMA’s patent: Does it still reflect an equipoise?","year":2021,"lang":"en","type":"article","venue":"Journal of Generic Medicines The Business Journal for the Generic Medicines Sector","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"TRIPS architecture; TRIPS Agreement; Intellectual property; Biosimilar; Access to medicines; Patent troll; Term (time); Business; Law and economics; Patent Act; Patent infringement; Protocol (science); International trade; Law; Patent law; Political science; Medicine; Economics; Engineering; Alternative medicine","score_opus":0.17793939434996314,"score_gpt":0.3030065297278441,"score_spread":0.12506713537788094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173567414","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008970676,0.01613748,0.03889084,0.2233857,0.0068598385,0.00014718594,0.00019365907,0.0003034558,0.7051111],"genre_scores_gemma":[0.5906371,0.01691998,0.033738207,0.08117002,0.00971581,0.0006899144,0.00021880327,0.0005261118,0.2663841],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99250656,0.002683761,0.000294275,0.0014372489,0.0022207536,0.0008574282],"domain_scores_gemma":[0.9920682,0.005299584,0.00037176927,0.000898038,0.0010381222,0.00032424962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00896796,0.0005667428,0.00059308065,0.0022306351,0.0072852555,0.0128429225,0.002006371,0.011200712,0.016255608],"category_scores_gemma":[0.025441673,0.00049966597,0.0006148237,0.0018277976,0.03018382,0.022306466,0.0039373925,0.016017998,0.003240656],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000037886718,0.0000022431175,0.000027565764,0.000012348458,0.0000010000282,0.000039508963,0.0005173873,0.000025196716,0.000033119035,0.9876654,0.0067496435,0.0049226196],"study_design_scores_gemma":[0.000012184261,0.000037140144,0.0002976522,0.00021150227,0.000008655158,0.00028116183,0.0007648531,0.00043540364,0.00020761034,0.51664215,0.4810656,0.000036029403],"about_ca_topic_score_codex":0.0143693695,"about_ca_topic_score_gemma":0.00926305,"teacher_disagreement_score":0.016255608,"about_ca_system_score_codex":0.0075156516,"about_ca_system_score_gemma":0.010000542,"threshold_uncertainty_score":0.054530144},"labels":[],"label_agreement":null},{"id":"W3183715790","doi":"10.1177/17411343211035168","title":"Brand drug companies impeding generic drug company access to product samples: Estimated prevalence and impact on drug costs","year":2021,"lang":"en","type":"article","venue":"Journal of Generic Medicines The Business Journal for the Generic Medicines Sector","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"Association canadienne du médicament générique","keywords":"Generic drug; Drug; Business; Market share; Brand names; Product (mathematics); Drug development; Marketing; Competition (biology); Order (exchange); Medicine; Pharmacology; Finance","score_opus":0.13494569130732337,"score_gpt":0.3561349865959504,"score_spread":0.22118929528862702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183715790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797346,0.003928719,0.0012823162,0.0007249627,0.00001221638,0.00022682281,0.009666465,0.000024591967,0.004399288],"genre_scores_gemma":[0.99169743,0.002165059,0.0006850102,0.00008769075,0.000020428832,0.000046721856,0.004332291,0.000007982319,0.0009573263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99457127,0.0011486013,0.00056571944,0.0005659084,0.001977424,0.0011710247],"domain_scores_gemma":[0.95446557,0.015322454,0.023708817,0.0012465878,0.0035969126,0.0016595884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004700759,0.0004167932,0.00058020145,0.0053431955,0.0006131367,0.0024214748,0.0012350249,0.00079421856,0.0037619597],"category_scores_gemma":[0.031942155,0.00062199426,0.0014965186,0.0063065332,0.0012540944,0.0014382469,0.0018896258,0.0014725127,0.00034102233],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008962649,0.000051271814,0.99032253,0.00010605576,0.00018212036,0.000105945364,0.00013966783,0.0013405208,0.000038696347,0.0007637114,0.00062524073,0.0062345834],"study_design_scores_gemma":[0.000013180119,0.00005363708,0.99215573,0.00010533959,0.00021375428,0.00026162813,0.00067380123,0.0044319606,0.00018604193,0.00028655113,0.0016029424,0.000015350979],"about_ca_topic_score_codex":0.41493052,"about_ca_topic_score_gemma":0.3823254,"teacher_disagreement_score":0.41493052,"about_ca_system_score_codex":0.008933621,"about_ca_system_score_gemma":0.0044940617,"threshold_uncertainty_score":0.8250307},"labels":[],"label_agreement":null},{"id":"W3196294283","doi":"10.1177/17411343211029995","title":"Comparison of generic drug registration strategies between health Canada and Gulf Cooperation Council","year":2021,"lang":"en","type":"article","venue":"Journal of Generic Medicines The Business Journal for the Generic Medicines Sector","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Innovator; Product (mathematics); Health care; Business; Quality (philosophy); Political science; Finance; Law","score_opus":0.19154054837280224,"score_gpt":0.33928873365898493,"score_spread":0.1477481852861827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196294283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6887088,0.01841532,0.0022001474,0.019272363,0.00026529393,0.0011488186,0.009924563,0.00028665696,0.25977805],"genre_scores_gemma":[0.9668046,0.0051865466,0.0017394674,0.0023543455,0.00005056245,0.00011072064,0.004588134,0.000051027393,0.019114563],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9886363,0.0014165173,0.00046756663,0.000604604,0.0055923024,0.003282736],"domain_scores_gemma":[0.9839536,0.0024373098,0.0015861163,0.00041569822,0.008698087,0.0029092294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065694284,0.00031905176,0.00041982756,0.0051596505,0.0025979832,0.00465376,0.0014341322,0.00094410434,0.0064686574],"category_scores_gemma":[0.01812949,0.00026135598,0.0008524931,0.0077639446,0.0011752319,0.001046025,0.0015867059,0.001039723,0.0007430381],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035901216,0.0007843312,0.33307773,0.002061025,0.0004577193,0.0013425921,0.005597112,0.00816925,0.0026152213,0.102886856,0.13995075,0.3994674],"study_design_scores_gemma":[0.0005147316,0.00085356936,0.7451554,0.000691086,0.00040840034,0.0007819918,0.013031625,0.008541333,0.0027451606,0.0020970479,0.22495489,0.00022471696],"about_ca_topic_score_codex":0.928651,"about_ca_topic_score_gemma":0.9440965,"teacher_disagreement_score":0.9400296,"about_ca_system_score_codex":0.059970386,"about_ca_system_score_gemma":0.11164896,"threshold_uncertainty_score":0.43511766},"labels":[],"label_agreement":null},{"id":"W4312203309","doi":"10.1177/17411343221146094","title":"Abbreviated new drug submission approval process: An overview","year":2022,"lang":"en","type":"article","venue":"Journal of Generic Medicines The Business Journal for the Generic Medicines Sector","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bioequivalence; Innovator; Generic drug; Brand names; Product (mathematics); Drug; Business; Medical prescription; Prescription drug; Pharmacology; Marketing; Medicine; Mathematics; Finance; Pharmacokinetics","score_opus":0.17414686862717058,"score_gpt":0.34405085586261713,"score_spread":0.16990398723544656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312203309","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0059932694,0.17151815,0.2377299,0.06094881,0.011380008,0.0159563,0.015704615,0.011803491,0.46896544],"genre_scores_gemma":[0.08677093,0.24424472,0.30623272,0.054932017,0.01819601,0.018186728,0.020365374,0.004386913,0.2466846],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.92530024,0.025037367,0.012434755,0.0042235367,0.030042354,0.0029617678],"domain_scores_gemma":[0.8818678,0.033791374,0.017205458,0.012367003,0.050276894,0.004491404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.065683834,0.0016192896,0.0015111285,0.0069805174,0.0023714462,0.012240243,0.0042217355,0.005917929,0.035685357],"category_scores_gemma":[0.08363484,0.0017768593,0.0023932843,0.010137037,0.0028184084,0.009674771,0.004185536,0.0051404354,0.053927273],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032830558,0.00026014922,0.002069923,0.0038578298,0.00006924192,0.0004047697,0.00026921617,0.0022379209,0.0013874618,0.10105898,0.38713056,0.50092554],"study_design_scores_gemma":[0.000041817504,0.00018576847,0.0037709104,0.0007102362,0.000030191311,0.00072110095,0.000059185277,0.00096360256,0.0006029723,0.0065969056,0.98625076,0.00006655527],"about_ca_topic_score_codex":0.010341125,"about_ca_topic_score_gemma":0.009229113,"teacher_disagreement_score":0.065683834,"about_ca_system_score_codex":0.009646417,"about_ca_system_score_gemma":0.030069336,"threshold_uncertainty_score":0.3473735},"labels":[],"label_agreement":null},{"id":"W4408631771","doi":"10.1177/17411343251327092","title":"An assessment of Canada’s revised Patented Medicines (Notice of Compliance) Regulations","year":2025,"lang":"en","type":"article","venue":"Journal of Generic Medicines The Business Journal for the Generic Medicines Sector","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"Association canadienne du médicament générique","keywords":"Notice; Compliance (psychology); Business; Law; Medicine; Accounting; Political science; Psychology","score_opus":0.14597300212516692,"score_gpt":0.31736578692687645,"score_spread":0.17139278480170952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408631771","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13530788,0.014984832,0.005798341,0.20722425,0.0034483306,0.0036150417,0.018628426,0.001594324,0.6093985],"genre_scores_gemma":[0.7014683,0.009559419,0.017951857,0.099941775,0.001212426,0.0007802427,0.009872184,0.00026319548,0.15895055],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.8699204,0.004819239,0.0036792436,0.0017498528,0.108750105,0.011081164],"domain_scores_gemma":[0.87607926,0.020616015,0.006172966,0.001992616,0.088088825,0.0070502567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.029571075,0.00072918425,0.0006602851,0.009405078,0.0058954824,0.012418714,0.00562919,0.008708041,0.0046103992],"category_scores_gemma":[0.07671024,0.00086071,0.0018932177,0.0065122982,0.0029522437,0.0017783493,0.0017832731,0.004813271,0.0006446516],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0004274521,0.00052457774,0.048323713,0.0016819075,0.00023810234,0.0017138986,0.0038652045,0.007907699,0.0058358894,0.24302426,0.5569806,0.12947673],"study_design_scores_gemma":[0.00014304557,0.00036614845,0.15823989,0.0007295439,0.00020069117,0.0002736429,0.0013656906,0.0030401533,0.00199206,0.0028695557,0.8304433,0.00033625765],"about_ca_topic_score_codex":0.9764954,"about_ca_topic_score_gemma":0.97791266,"teacher_disagreement_score":0.8573742,"about_ca_system_score_codex":0.14262582,"about_ca_system_score_gemma":0.35989666,"threshold_uncertainty_score":0.9944325},"labels":[],"label_agreement":null}]}